Amgen, short for Applied Molecular Genetics, is a leading global biopharmaceutical company headquartered in Thousand Oaks, California. Founded in 1980, its mission revolves around discovering, developing, manufacturing, and delivering innovative human therapeutics. The company is publicly traded and its ownership is diversified among individual and institutional shareholders. Amgen boasts a global presence, extending its operations across the Americas, Europe, and Asia-Pacific regions. With an unwavering commitment to science and innovation, Amgen has played a pioneering role in developing breakthrough therapies for grievous illnesses.